Aidigong Maternal and Infant Health Co., Ltd. ('Aidigong') plans to hold a special shareholders' meeting on July 25, 2024 to consider proposals for the merger of shares and the issuance of new shares based on special authorization. The share merger will combine every forty existing shares with a par value of HKD 0.01 into one merged share with a par value of HKD 0.4. In addition, the company and the distribution agent Beta International Securities Limited signed a distribution agreement on June 20, 2024, proposing to distribute up to 44,350,000 new merged shares at a price of HKD 1.68 per share. The distribution matter can only proceed after the share merger is effective and approved by the special shareholders' meeting. The company stated that the net proceeds from...Show More

Aidigong Maternal and Infant Health Co., Ltd. ('Aidigong') plans to hold a special shareholders' meeting on July 25, 2024 to consider proposals for the merger of shares and the issuance of new shares based on special authorization. The share merger will combine every forty existing shares with a par value of HKD 0.01 into one merged share with a par value of HKD 0.4. In addition, the company and the distribution agent Beta International Securities Limited signed a distribution agreement on June 20, 2024, proposing to distribute up to 44,350,000 new merged shares at a price of HKD 1.68 per share. The distribution matter can only proceed after the share merger is effective and approved by the special shareholders' meeting. The company stated that the net proceeds from the distribution matter are approximately HKD 72,114,000, which will be used to repay group loans and other payables, as well as for general operating capital. The share merger and the issuance of new shares aim to increase the company's share price and the value of each trading unit, attract more investors and broaden shareholder base.